← ICICI Prudential Mutual Fund
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - Cumulative Option
Open Ended Schemes(Equity Scheme - Sectoral/ Thematic)Very High RiskISIN INF109KC1GH2
NAV · 06-Jul-2026
₹47.3300
1M
+6.60%
6M
+9.49%
1Y (CAGR)
+10.52%
3Y (CAGR)
+26.94%
5Y (CAGR)
+16.97%
Since inception (CAGR)
+21.70%
NAV history
hover for values
Risk & SIP analytics
Q1 · TOP · 3Y in categoryVolatility (3y)
13.63%
Downside dev (3y)
9.64%
Max drawdown (3y)
-16.2%
Sharpe (3y)
1.50
SIP XIRR (3y)
+18.45%
SIP XIRR (5y)
+21.96%
Calendar-year returns
2020 +73.5%2021 +19.3%2022 -7.6%2023 +42.5%2024 +49.4%2025 +0.1%
Fund facts
Fund managerDharmesh Kakkad · Sharmila D’mello
AUM₹64,535 Cr
Expense ratio0.87% · 2026-05-31
Launch date25-Jun-2018
Plan typeOpen Ended · Equity
Min lumpsum₹5,000
Min SIP₹100
Lock-inNone
Volatility15.15
AMCICICI Prudential Asset Management Company Limited
Objective · To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
scheme documents ↗